Skip to main content
. 2023 Jun 15;25:32. doi: 10.1186/s12968-023-00944-x

Table 2.

Basal clinical and CMR characteristics of MVP cVA and MVP noVA

MAD cVA
(23 patient)
MAD noVA
(19 patient)
P value
Age (± SD) 46.6 ± 13.0 49.6 ± 17.8 0.198
Male gender (%) 10 (43%) 11 (57%) 0.887
BMI (± SD) 26.4 ± 4.5 24.1 ± 4.7 0.612
BSA (m2 ± SD) 1.7 ± 0.2 1.8 ± 0.3 0.452
EDV (ml ± SD) 181.4 ± 48.2 184.3 ± 46.1 0.468
EDVi (ml/m2 ± SD) 98.0 ± 25.9 98.4 ± 29.2 0.421
ESV (ml ± SD) 79.6 ± 25.1 83.2 ± 34.2 0.537
EF (% ± SD) 55.9 ± 8.4 57.2 ± 6.8 0.833
LV mass (g/m2 ± SD) 62.3 ± 12.4 71.9 ± 14.2 0.486
MAD length (mm ± SD) 10.3 ± 4.5 [7.3–12.3] 9.2 ± 4.4 [6.7–11.5] 0.417
MR
– Mild 3 (13%) 4 (21%)
– Moderate 14 (61%) 11 (58%)
– Severe 6 (26%) 4 (21%)
LGE 18 (78%) 8 (42%) 0.0002
Native T1 mapping (ms (± SD)
– Anterior wall 1021 ± 54 1011 ± 93 0.634
– Anterolateral wall 1052 ± 56 1051 ± 65 0.401
– Inferolateral wall 1104 ± 63 1074 ± 63 0.026
– Inferior wall 1116 ± 58 1087 ± 58 0.015
– Inferoseptal wall 1085 ± 59 1082 ± 48 0.167
– Anteroseptal wall 1062 ± 40 1054 ± 44 0.611
– Mean 1083 ± 41 1044 ± 52 0.039
ECV (% ± SD)
– Anterior wall 0.27 ± 0.04 0.27 ± 0.04 0.336
– Anterolateral wall 0.29 ± 0.03 0.29 ± 0.05 0.464
– Inferolateral wall 0.31 ± 0.05 0.30 ± 0.04 0.221
– Inferior wall 0.31 ± 0.03 0.30 ± 0.02 0.307
– Inferoseptal wall 0.29 ± 0.03 0.29 ± 0.04 0.87
– Anteroseptal wall 0.28 ± 0.04 0.30 ± 0.03 0.235
– Mean 0.30 ± 0.04 0.29 ± 0.04 0.791
GLS (± SD) − 18.2 ± 4.6 − 25.1 ± 3.1 0.004
LS basal (± SD)
– Anterior wall − 17.0 ± 8.2 − 17.9 ± 9.1 0.924
– Anterolateral wall − 22.8 ± 8.3 − 22.1 ± 7.4 0.288
– Inferolateral wall − 21.1 ± 11.0 − 24.9 ± 9.3 0.459
– Inferior wall − 16.8 ± 7.9 − 23.1 ± 7.0 0.007
– Inferoseptal wall − 18.6 ± 6.3 − 20.8 ± 9.8 0.245
– Anteroseptal wall − 27.5 ± 13.1 − 24.3 ± 8.1 0.718
– Mean − 24.3 ± 8.1 − 22.9 ± 9.1 0.341
LS mid-wall (± SD)
– Anterior wall − 25.8 ± 10.7 − 26.2 ± 8.3 0.719
– Anterolateral wall − 24.2 ± 7.3 − 29.7 ± 7.6 0.63
– Inferolateral wall − 30.8 ± 7.6 − 26.5 ± 6.3 0.071
– Inferior wall − 29.5 ± 6.8 − 28.6 ± 6.1 0.76
– Inferoseptal wall − 24.2 ± 7.3 − 25.3 ± 7.2 0.994
– Anteroseptal wall − 22.4 ± 8.2 − 21.0 ± 7.6 0.183
– Mean − 24.5 ± 7.2 − 24.5 ± 8.4 0.147
LS apical (± SD)
– Anterior wall − 27.6 ± 13.9 − 28.0 ± 11.2 0.679
– Septal wall − 22.3 ± 8.0 − 29.7 ± 12.6 0.154
– Inferior wall − 27.0 ± 12.8 − 29.7 ± 12.6 0.28
– Lateral wall − 26.9 ± 7.0 − 28.0 ± 7.0 0.253
– Mean − 29.0 ± 10.9 − 34.6 ± 11.0 0.131
CS basal (± SD)
– Anterior wall − 24.5 ± 5.4 − 26.1 ± 6.5 0.315
– Anterolateral wall − 25.8 ± 5.5 − 25.6 ± 5.5 0.887
– Inferolateral wall − 19.5 ± 7.6 − 27.4 ± 7.5 0.0001
– Inferior wall − 19.6 ± 6.2 − 26.2 ± 6.6 0.0078
– Inferoseptal wall − 23.1 ± 5.0 − 24.4 ± 5.9 0.927
– Anteroseptal wall − 23.1 ± 5.0 − 26.1 ± 7.4 0.713
– Mean − 22.4 ± 4.5 − 24.7 ± 6.4 0.765
CS midventricular (± SD)
– Anterior wall − 20.7 ± 4.8 − 20.3 ± 3.4 0.359
– Anterolateral wall − 22.1 ± 6.7 − 20.3 ± 4.3 0.21
– Inferolateral wall 14.7 ± 8.2 18.9 ± 6.9 0.053
– Inferior wall − 23.3 ± 8.1 − 24.3 ± 7.5 0.526
– Inferoseptal wall − 22.1 ± 6.9 − 19.9 ± 5.5 0.273
– Anteroseptal wall − 23.2 ± 5.2 − 19.7 ± 9.9 0.245
– Mean − 17.5 ± 4.7 − 21.6 ± 3.1 0.041
CS apical (± SD)
– Anterior wall − 32.5 ± 16.1 − 24.8 ± 7.2 0.579
– Septal − 26.3 ± 32.0 − 31.9 ± 8.0 0.097
– Inferior − 38.6 ± 12.4 − 35.0 ± 15.3 0.715
– Lateral − 34.1 ± 20.2 − 31.6 ± 4.4 0.614
– Mean − 30.8 ± 8.6 − 33.1 ± 5.4 0.561

Statistically significant values are highlighted in bold

BMI body mass index, cVA complex ventricular arrythmias, EDV end-diastolic volume, EDVi end-diastolic volume indexed. ESV end-systolic volume, EF ejection fraction, LV left ventricle, MAD mitral annular disjunction, MR mitral regurgitation, noVA no complex ventricular arrhythmias, ECV extracellular volume, GLS global longitudinal strain, LS longitudinal strain, CS circumferential strain